BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17065061)

  • 1. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells.
    Karim H; Hashemi J; Larsson C; Moshfegh A; Fotoohi AK; Albertioni F
    Biochem Biophys Res Commun; 2011 Jul; 411(1):156-61. PubMed ID: 21723252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
    Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
    Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
    Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
    Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
    Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
    Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes.
    Petit E; Langouet S; Akhdar H; Nicolas-Nicolaz C; Guillouzo A; Morel F
    Toxicol In Vitro; 2008 Apr; 22(3):632-42. PubMed ID: 18222062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of thiopurine drugs on DNA methylation in relation to TPMT expression.
    Hogarth LA; Redfern CP; Teodoridis JM; Hall AG; Anderson H; Case MC; Coulthard SA
    Biochem Pharmacol; 2008 Oct; 76(8):1024-35. PubMed ID: 18708030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.
    Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P
    Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
    Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ
    Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
    Zimm S; Johnson GE; Poplack DG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
    Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
    Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited intra-individual variability in hypoxanthine-Guanine phosphoribosyl transferase, thiopurine S-methyl transferase, and xanthine oxidase activity in inflammatory bowel disease patients during 6-thioguanine therapy.
    van Asseldonk DP; de Boer NK; Smid K; Mulder CJ; van Bodegraven AA; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):284-90. PubMed ID: 20544508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
    Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
    Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen.
    Gunnarsdottir S; Elfarra AA
    Drug Metab Dispos; 2004 Mar; 32(3):321-7. PubMed ID: 14977866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
    Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical basis of the prevention of 6-thiopurine toxicity by the nucleobases, hypoxanthine and adenine.
    Hashimoto H; Kubota M; Shimizu T; Takimoto T; Kitoh T; Akiyama Y; Mikawa H
    Leuk Res; 1990; 14(11-12):1061-6. PubMed ID: 2280604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers.
    Coulthard SA; Redfern CP; Vikingsson S; Lindqvist-Appell M; Skoglund K; Jakobsen-Falk I; Hall AG; Taylor GA; Hogarth LA
    Mol Cancer Ther; 2011 Mar; 10(3):495-504. PubMed ID: 21282358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased 6-mercaptopurine retention by two resistant variants of mouse neuroblastoma with normal hypoxanthine-guanine-phospho-ribosyltransferase activities.
    Baskin F; Rosenberg RN
    J Pharmacol Exp Ther; 1975 Apr; 193(1):293-300. PubMed ID: 1169317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.